Distribution and comparison of receptors for leukemia inhibitory factor on murine hemopoietic and hepatic cells
- PMID: 1900303
- DOI: 10.1002/jcp.1041460204
Distribution and comparison of receptors for leukemia inhibitory factor on murine hemopoietic and hepatic cells
Abstract
Leukemia inhibitory factor (LIF) is a glycoprotein that induces the differentiation of the monocytic leukemia cell line M1 but suppresses the differentiation of totipotent embryonic stem cells. In an attempt to define the normal cellular targets for LIF, the distribution of LIF receptors within hemopoietic and hepatic tissue was analyzed by binding cells with radioiodinated LIF (125I-LIF) and subsequently carrying out autoradiography. Autoradiography demonstrated that in each hemopoietic tissue examined cells of monocyte/macrophage lineage were the primary cell type labeled with 125I-LIF. Moreover, both fetal and adult parenchymal hepatocytes displayed higher levels of labeling than either monocytes or macrophages. The number of receptors per positive cell varied from 150 for bone marrow monocytes to 2,000 for adult hepatocytes. In each case, however, binding was of high affinity, with an apparent KD of 34-100 pM, and binding was specific, since labeling was competed for by unlabeled LIF but not a range of other structurally unrelated growth and differentiation factors. It is suggested that LIF may play a role in regulating macrophage function and hepatic acute phase protein synthesis in response to infection.
Similar articles
-
Specific binding of leukemia inhibitory factor to murine myoblasts in culture.J Cell Physiol. 1995 Jul;164(1):93-8. doi: 10.1002/jcp.1041640112. J Cell Physiol. 1995. PMID: 7790402
-
Oncostatin M is a differentiation factor for myeloid leukemia cells.J Immunol. 1992 Aug 15;149(4):1271-5. J Immunol. 1992. PMID: 1380037
-
AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.J Clin Invest. 1995 Sep;96(3):1319-27. doi: 10.1172/JCI118167. J Clin Invest. 1995. PMID: 7657807 Free PMC article.
-
The unsolved enigmas of leukemia inhibitory factor.Stem Cells. 2003;21(1):5-14. doi: 10.1634/stemcells.21-1-5. Stem Cells. 2003. PMID: 12529546 Review.
-
Role of leukemia inhibitory factor during mammalian development.Eur Cytokine Netw. 1996 Dec;7(4):699-712. Eur Cytokine Netw. 1996. PMID: 9010672 Review.
Cited by
-
Molecular dynamics simulations reveal key roles of the LIF receptor in the assembly of human LIF signaling complex.Comput Struct Biotechnol J. 2025 Jan 27;27:585-594. doi: 10.1016/j.csbj.2025.01.014. eCollection 2025. Comput Struct Biotechnol J. 2025. PMID: 39989618 Free PMC article.
-
A continuous culture of pluripotent fetal hepatocytes derived from the 8-day epiblast of the pig.In Vitro Cell Dev Biol Anim. 1994 Dec;30A(12):843-50. doi: 10.1007/BF02639394. In Vitro Cell Dev Biol Anim. 1994. PMID: 7534591
-
Murine hematopoietic stem cells committed to macrophage/dendritic cell formation: stimulation by Flk2-ligand with enhancement by regulators using the gp130 receptor chain.Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11552-6. doi: 10.1073/pnas.94.21.11552. Proc Natl Acad Sci U S A. 1997. PMID: 9326647 Free PMC article.
-
Mechanism of sorafenib resistance associated with ferroptosis in HCC.Front Pharmacol. 2023 Jun 7;14:1207496. doi: 10.3389/fphar.2023.1207496. eCollection 2023. Front Pharmacol. 2023. PMID: 37351514 Free PMC article. Review.
-
Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2024 Dec 19;11:2493-2504. doi: 10.2147/JHC.S500084. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39717509 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical